Guru Ownership Trend
Guru Analysis for Madrigal Pharmaceuticals, Inc. (MDGL)
Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $884.68 M.
Top institutional holders include John Paulson and Steven Cohen.
Notably, John Paulson has expressed high conviction in this stock, allocating 23.42% of their equity portfolio to it.
Institutional sentiment is currently Bearish. This is evidenced by a $121.16 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 120.1%. Conversely, Ray Dalio reduced exposure by 79.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Madrigal Pharmaceuticals, Inc. (MDGL)
Major holders include John Paulson ($728.77 M), Steven Cohen ($118.05 M), Renaissance Technologies (RenTech) ($37.62 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.72 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $121.16 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited MDGL. The total reported sell value was $179.46 M.
Yes, 0 managers opened new positions in MDGL, and 3 increased their existing holdings. The total reported buy value was $58.3 M.
